1027409-06-8

Upstream product

• 1027508-87-7 4-[4-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-1-{(R)-3-[4-(tert-butyl-dimethyl-silanyloxy)-phenyl]-3-hydroxy-cyclohexylmethyl}-piperidin-4-ol 
• 67963-68-2 t-butyldimethylsilyl-4-bromophenol 
• 177-11-7 4,4-ethylenedioxy-piperidine 
• 171522-33-1 (R)-1-<(3-oxocyclohexyl)methyl>piperidin-4-one 
• 1026598-15-1 8-[(R)-1-(1,4-Dioxa-spiro[4.5]dec-7-yl)methyl]-1,4-dioxa-8-aza-spiro[4.5]decane 
• 171522-32-0 (R)-3-(1,4-dioxa-8-azaspiro<4.5>dec-8-ylcarbonyl)cyclohexanone 
• 1025980-56-6 (1,4-Dioxa-8-aza-spiro[4.5]dec-8-yl)-(R)-1,4-dioxa-spiro[4.5]dec-7-yl-methanone 

Relevant academic research and scientific papers

Identification, characterization and pharmacological profile of three metabolites of (R)-(+)-1,2,3,6-tetrahydro-4-phenyl-1-[(3-phenylcyclohexen-1- yl)methyl]pyridine (CI-1007), a dopamine autoreceptor agonist and potential antipsychotic agent

Liquid chromatographic-mass spectrometric (LC-MS) analysis of plasma taken from cynomolgus monkeys dosed orally with (R)-(+)-1,2,3,6-tetrahydro-4- phenyl-1-[(3-phenylcyclohexen-1-yl)methyl]pyridine (1), a dopamine (DA) autoreceptor agonist and potential a